Non-adherence to highly active antiretroviral therapy predicts progression to AIDS

被引：749

作者：

Bangsberg, DR ^{[1
]}

Perry, S

Charlebois, ED

Clark, RA

Roberston, M

Zolopa, AR

Moss, A

机构：

[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA

[4] Inst Publ Hlth, Alcohol Res Grp, Berkeley, CA USA

[5] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA

来源：

AIDS | 2001年 / 15卷 / 09期

关键词：

D O I：

10.1097/00002030-200106150-00015

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1181 / 1183

页数：3

共 16 条

[1] HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial:: an extended virology study [J].

Aboulker, JP ;

Babiker, AG ;

Brun-Vézinet, F ;

Darbyshire, JH ;

Flandre, P ;

Gazzard, B ;

Nunn, AJ ;

Goodall, R ;

Aber, V ;

Bragman, K ;

Breckenridge, AM ;

Carbon, C ;

Charreau, I ;

Chene, G ;

Collis, P ;

Cooper, D ;

Dormont, J ;

Fiddian, P ;

Flepp, M ;

Goebel, FD ;

Hooker, M ;

Lange, J ;

Lüthy, R ;

Peto, TEA ;

Reiss, P ;

Seligmann, M ;

Stone, AB ;

Thomis, J ;

Vella, S ;

Walckenaer, G ;

Warrell, D ;

Weller, IVD ;

Wilber, R ;

Yeni, P ;

Yeo, J ;

Withnall, R ;

Goudsmit, J ;

Huraux, JM ;

van der Noorda, J ;

Weiss, R ;

Boucher, C ;

Schuurman, R ;

Descamps, D ;

Jeffries, D ;

Tedder, R ;

Weber, J ;

Krzyanowski, C ;

Weverling, G .

AIDS, 1999, 13 (01) :57-65

[2] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].

Bangsberg, DR ;

Hecht, FM ;

Charlebois, ED ;

Zolopa, AR ;

Holodniy, M ;

Sheiner, L ;

Bamberger, JD ;

Chesney, MA ;

Moss, A .

AIDS, 2000, 14 (04) :357-366

[3]

CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9

[4]

FISCHL M, 2000, C RETR OPP INF SAN F

[5]

Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386

[6] The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response [J].

Haubrich, RH ;

Little, SJ ;

Currier, JS ;

Forthal, DN ;

Kemper, CA ;

Beall, GN ;

Johnson, D ;

Dubé, MP ;

Hwang, JY ;

McCutchan, JA .

AIDS, 1999, 13 (09) :1099-1107

[7] Impact of HIV on adult (15-54) mortality in London: 1979-96 [J].

Hickman, M ;

Bardsley, M ;

De Angelis, D ;

Ward, H .

SEXUALLY TRANSMITTED INFECTIONS, 1999, 75 (06) :385-388

[8]

HOGG R, 2000, 13 INT AIDS C DURB

[9] Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions [J].

Lucas, GM ;

Chaisson, RE ;

Moore, RD .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (02) :81-+

[10] Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].

Mellors, JW ;

Rinaldo, CR ;

Gupta, P ;

White, RM ;

Todd, JA ;

Kingsley, LA .

SCIENCE, 1996, 272 (5265) :1167-1170

← 1 2 →